Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5799
-1.71 %
$ 148 M
Market Cap
-3.41
P/E
ADAP - OPERATING EXPENSES
Operating Expenses ADAP - Adaptimmune Therapeutics plc
188 M
LAST VALUE
5.78%
2 YEAR CAGR
5.84%
5 YEAR CAGR
35.03%
10 YEAR CAGR